CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
76 hedge funds and large institutions have $104M invested in Carisma Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 1.07% → 1.18% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less call options, than puts
Call options by funds: $2.58M | Put options by funds: $3.2M
Holders
76
Holding in Top 10
1
Calls
$2.58M
Puts
$3.2M
Top Buyers
| 1 | +$7.81M | |
| 2 | +$6.82M | |
| 3 | +$5.88M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.38M |
| 5 |
BlackRock
New York
|
+$2.65M |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$2.11M | |
| 3 | -$1.95M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$1.04M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$454K |